Aaron Cowen Suvretta Capital Management
Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$62.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$46.1M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$45.9M |
| 4 |
Fidelity National Information Services
FIS
|
+$44M |
| 5 |
Royalty Pharma
RPRX
|
+$43.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$147M |
| 2 |
Microsoft
MSFT
|
+$93.8M |
| 3 |
S&P Global
SPGI
|
+$84.8M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$82.9M |
| 5 |
Johnson & Johnson
JNJ
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.98% |
| 2 | Industrials | 11.58% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Technology | 7.11% |
| 5 | Financials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wynn Resorts
WYNN
$10.3B
| – | – |
-366,060
| Closed | -$29.2M |
|
102
Xenon Pharmaceuticals
XENE
$5.88B
| – | – |
-692,000
| Closed | -$21.2M |
|
103
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| – | – |
-1,385,736
| Closed | -$53M |
|
104
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
| – | – |
-164,970
| Closed | -$22.2M |
|
|
OHAAU
105
DELISTED
OPY Acquisition Corp. I Units
OHAAU
| – | – |
-200,000
| Closed | -$2M |
|
|
CANO
106
DELISTED
Cano Health, Inc.
CANO
| – | – |
-36,685
| Closed | -$23.3M |
|
|
DBTX
107
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| – | – |
-263,600
| Closed | -$801K |
|
|
EUCRW
108
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
| – | – |
-33,333
| Closed | -$6K |
|
|
EBACW
109
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
| – | – |
-100,000
| Closed | -$20K |
|
|
FLACW
110
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
| – | – |
-29,166
| Closed | -$7K |
|
Similar funds
Aaron Cowen's Q2 2022 Portfolio in Review
As of Q2 2022, Aaron Cowen held 110 positions worth $2.63B, down 20% from $3.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Aaron Cowen withdrew a net $229M in Q2 2022, closing 21 positions and reducing 18 holdings. Its most notable exit was Amazon, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 48% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Aaron Cowen opened a new position in Block Inc worth $41.8M.
- Aaron Cowen's largest Q2 2022 buy was Block Inc: 679,676 shares worth $41.8M.
- Aaron Cowen added most to Royalty Pharma in Q2 2022, an estimated $43.2M increase.
- Aaron Cowen's biggest Q2 2022 reduction was Microsoft, cutting an estimated $93.8M.
- Aaron Cowen fully exited Amazon in Q2 2022, selling an estimated $147M.
- Aaron Cowen's ten largest holdings make up 36% of its $2.63B portfolio in Q2 2022.
- Aaron Cowen opened 23 new positions and closed 21 in Q2 2022.
- Aaron Cowen's portfolio value fell 20% quarter-over-quarter to $2.63B.
Based on Suvretta Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.